Menu
Not yet recruiting NCT07674914

A Cognitive Mobile Intervention for Motivation in Psychotic Disorders

Phase I / Phase II Interventional Schizophrenia / Schizoaffective Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Cognitive Training, Mobile cognitive training.
Who it may be relevant to
Registry conditions: Schizophrenia / Schizoaffective Disorder. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A User-Informed Digital Therapeutic for Specific Cognitive Disabilities to Improve Mental Health in Schizophrenia and Related Mental Illnesses

Overview

The goal of this study is to develop and test the impact of a smartphone-based working memory cognitive training digital therapeutic for individuals with schizophrenia or a related disorder.

Interventions

  • Behavioral Cognitive Training
    This will be a digital cognitive training program.
  • Behavioral Mobile cognitive training
    This will be a remotely delivered mobile cognitive intervention via a smartphone application.

Primary outcome measures

  • Change in number correct in letter number span working memory test [Time frame: Day 1 and Day 16]

Eligibility criteria

Inclusion criteria

  • diagnosis of schizophrenia, schizoaffective disorder, or a related psychotic disorder
  • own a smartphone
  • English speaking
  • experiencing challenges with cognitive functioning
  • no changes to antipsychotic medication in past month

Exclusion criteria

  • history of neurological disorder
  • traumatic brain injury with loss of consciousness > 10 minutes or behavioral sequelae.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • University of Alabama at Birmingham — Birmingham

Identifiers

NCT: NCT07674914 · IRB-300016943 · UAB's CEDHARS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗